Nifty ends above 5550; RIL, Sun Pharma, JP Associates gain

	Dated:07 June,2011

Market Round-up SENSEX 18495.62 75.51 NIFTY 5556.15 24.10 NASDAQ 2141.54 17.78 DJIA 10060.06 19.61 RS/$ 46.79 -0.14 NSE Gainers Scrip Price(Rs.) %Change Sujana Universal Industri 6.45 + 20.56 Pearl Polymers Ltd. 17.95 + 20.07 Steel Strips Wheels Ltd. 287.50 + 14.02 Parekh Aluminex Ltd. 290.45 + 13.79 Alpha Geo (India) Ltd. 113.75 + 12.12 NSE Losers Scrip Price(Rs.) %Change Nu Tek India Ltd. 5.00 -13.79 Aanjaneya Lifecare Ltd. 335.35 -10.98 Vimta Labs Ltd. 30.80 -9.94 Store One Retail India Lt 18.40 -8.68 Jenson & Nicholson (India 5.25 -6.25

Top Headlines Nifty ends above 5550; RIL, Sun Pharma, JP Associates gain Realty, oil & gas and technology stocks were top sectoral performers while capital goods and FMCG ended in the red. 'Markets to remain in current range till inflation peaks out' Banks and auto companies are the kind of stocks that we are looking at buying, says Hiren Vedof Alchemy Capital Management. Investors lacking confidence to bring money into markets: Deven Choksey Actions would return back to the investing side by the end of second quarter or beginning of third quarter, says Deven Choksey of Choksey Securities. Views on Stocks/Markets Raymond good pick in textile pack: Ashwani Gujral Bharti can climb a bit if Nifty supports: Technical Trends Buy Glenmark Pharma, Asian Paints: Ashwani Gujral IPO/Global Markets European shares rebound Nikkei flat World stocks fall Rupee / Gold Rupee up on dollar slide Silver surges on global cues Silver's glitter to last More 'Market' News Maruti stock drops as strike at Manesar plant continues Shares of the Maruti fell by 2.1% to touch a low of Rs 1,206 on BSE, while on NSE, it went down by 1.70% to hit an early low of Rs 1210.95. Tata Global to sell about 20% in intl operations; stock up Tata Global beverages , is in talks to sell about 20 pc in its international operations and expects to close a deal in few months. Investors critical of Jyothy Labs' lack of focus on growth biz Jyothy Laboratories' fourth quarter and 2010-11 results show growth in some of its main brands has dropped, analysts said.